Ciro L. Pierri

Via E. Orabona 4
Bari, 70125, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 96 publications

Mediterranean PAH Stratification in Phenylketonuria: Tracing Historical Maps to Point Toward Clinical Phenotype and Obesity Risk.

Mediterranean PAH Stratification in Phenylketonuria: Tracing Historical Maps to Point Toward Clinical Phenotype and Obesity Risk.

Journal: Genes

Published: May 28, 2026

Structural basis of ligand selectivity in FAD/NAD(P)H-dependent dehydrogenases: insights from trypanothione reductase and type II NADH dehydrogenase.

Structural basis of ligand selectivity in FAD/NAD(P)H-dependent dehydrogenases: insights from trypanothione reductase and type II NADH dehydrogenase.

Journal: Protein science : a publication of the Protein Society

Published: March 28, 2026

Suramin Interactions Across Biological Systems: From Molecular Targets to Therapeutic Implications.

Suramin Interactions Across Biological Systems: From Molecular Targets to Therapeutic Implications.

Journal: Biomolecules

Published: February 10, 2026

Unveiling the molecular crosstalk between the purinergic P2X7 receptor and cannabinoid subtype 2 receptor in human microglial HMC3 cells: New insights for multitarget therapies in neuroinflammation.

Unveiling the molecular crosstalk between the purinergic P2X7 receptor and cannabinoid subtype 2 receptor in human microglial HMC3 cells: New insights for multitarget therapies in neuroinflammation.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: February 06, 2026

Correction: Discovery of therapeutic AGC2 modulators by combining docking, binding, and vesicle-based transport assays.

Correction: Discovery of therapeutic AGC2 modulators by combining docking, binding, and vesicle-based transport assays.

Journal: Journal of translational medicine

Published: October 30, 2025

SLC25A mitochondrial carriers as biomarkers and therapeutic targets of spaceflight-induced dysfunction: the ADP/ATP carrier (AAC3) as a structural case study.

SLC25A mitochondrial carriers as biomarkers and therapeutic targets of spaceflight-induced dysfunction: the ADP/ATP carrier (AAC3) as a structural case study.

Journal: Journal of translational medicine

Published: October 15, 2025

Molecular mechanism of p-Coumaric acid in the regulation of AQP2 function through the activation of calcium-sensing receptor signaling.

Molecular mechanism of p-Coumaric acid in the regulation of AQP2 function through the activation of calcium-sensing receptor signaling.

Journal: Scientific reports

Published: October 02, 2025

Discovery of chalcone derivatives as antileishmanial agents: phenotypic screening, exploratory docking and enzymatic assays on trypanothione reductase and related flavoproteins.

Discovery of chalcone derivatives as antileishmanial agents: phenotypic screening, exploratory docking and enzymatic assays on trypanothione reductase and related flavoproteins.

Journal: Bioorganic chemistry

Published: September 26, 2025

Chronic fasudil treatment induces benzodiazepine-like tolerance via modulation of GABA-A receptor γ2 subunit expression and impairs contextual fear memory in mice.

Chronic fasudil treatment induces benzodiazepine-like tolerance via modulation of GABA-A receptor γ2 subunit expression and impairs contextual fear memory in mice.

Journal: Pharmacological reports : PR

Published: September 19, 2025

Structural insights from neuraminidase diversity: Implications for selectivity in anti-infective and anticancer strategies.

Structural insights from neuraminidase diversity: Implications for selectivity in anti-infective and anticancer strategies.

Journal: Advances in protein chemistry and structural biology

Published: September 19, 2025

COXFA4L2 upregulation preserves residual cytochrome c oxidase activity in COXFA4-related Leigh-like encephalopathy.

COXFA4L2 upregulation preserves residual cytochrome c oxidase activity in COXFA4-related Leigh-like encephalopathy.

Journal: Nature communications

Published: September 01, 2025

Discovery of therapeutic AGC2 modulators by combining docking, binding, and vesicle-based transport assays.

Discovery of therapeutic AGC2 modulators by combining docking, binding, and vesicle-based transport assays.

Journal: Journal of translational medicine

Published: May 23, 2025

Showing 1-12 of 96

Last Updated: 09/26/2026